Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone

Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone - Trial of prevention of preterm birth in women with prior preterm birth by vaginal progesterone

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023080

Enrollment

100

Registered

2016-08-01

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnant women at high risk of preterm birth

Interventions

Administration of vaginal progesterone capsule (200mg/dl) once daily between 16 and 34 weeks of gestations

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: women with prior preterm birth after second trimester

Exclusion criteria

Exclusion criteria: 1)prior preterm birth by induction for obstetrics complication 2)contraindication of progesterone 3)multiple pregnancy 4)fetus of severe anomaly or abnormal chromosome

Design outcomes

Primary

Measure	Time frame
rate of preterm birth	—

Countries

Japan

Contacts

Public ContactYuka Sato

Kyushu university hospital Comprehensive Maternity and Perinatal Care Center

s-yuka@med.kyushu-u.ac.jp092-641-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026